| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/10/2000 | DE19903920A1 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses |
| 08/10/2000 | DE19903506A1 Verfahren, Gefäß und Vorrichtung zur Überwachung der Stoffwechselaktivität von Zellkulturen in flüssigen Medien A method, vessel and apparatus for monitoring the metabolic activity of cell cultures in liquid media |
| 08/10/2000 | CA2492661A1 Non-stochastic generation of genetic vaccines and enzymes |
| 08/10/2000 | CA2362239A1 Novel rgs-containing molecules and uses thereof |
| 08/10/2000 | CA2362126A1 B7rp-1 polypeptides |
| 08/10/2000 | CA2361838A1 Method of treating cancer by restoration of pp32 function |
| 08/10/2000 | CA2361703A1 Tryptophan synthase as a site of herbicide action |
| 08/10/2000 | CA2361654A1 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
| 08/10/2000 | CA2361599A1 Methods of utilizing the tt virus |
| 08/10/2000 | CA2361038A1 Pigment protein from coral tissue |
| 08/10/2000 | CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin |
| 08/10/2000 | CA2360929A1 Genomic analysis method |
| 08/10/2000 | CA2360755A1 Method for detecting bacteria cultivated in anaerobic condition |
| 08/10/2000 | CA2360741A1 Protein with cell proliferation and cell division modulating activity and dna encoding such protein |
| 08/10/2000 | CA2360684A1 Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same |
| 08/10/2000 | CA2358680A1 New assay |
| 08/10/2000 | CA2358589A1 Method for predicting fiber length using qtl's and molecular markers |
| 08/10/2000 | CA2327413A1 Assay for asymmetrical dimethyl-l-arginine (adma) |
| 08/10/2000 | CA2325051A1 Reference material for nucleic acid amplification |
| 08/09/2000 | EP1026263A2 Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof |
| 08/09/2000 | EP1026262A2 Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof |
| 08/09/2000 | EP1026261A2 Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid |
| 08/09/2000 | EP1026260A1 Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays |
| 08/09/2000 | EP1026259A1 Dna chip and its preparation |
| 08/09/2000 | EP1026258A2 Multiplex genotyping of populations of individuals |
| 08/09/2000 | EP1026245A1 Antigen protein and nucleic acid coding for said protein |
| 08/09/2000 | EP1026244A1 Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B |
| 08/09/2000 | EP1026243A1 NUCLEIC ACID CAPABLE OF BINDING SPECIFICALLY TO Ras TARGET PROTEIN |
| 08/09/2000 | EP1026241A1 An improved method for preparing DNA from serum and plasma |
| 08/09/2000 | EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens |
| 08/09/2000 | EP1025758A1 Enhancing antimicrobial activity |
| 08/09/2000 | EP1025443A1 Method for evaluating an effect characteristic of a biochemically active stimulation means |
| 08/09/2000 | EP1025439A1 Membrane based electrochemical test device and related methods |
| 08/09/2000 | EP1025266A1 Catalytic nucleic acid-based diagnostic methods |
| 08/09/2000 | EP1025265A1 Methods for detecting contamination in molecular diagnostics using pcr |
| 08/09/2000 | EP1025264A1 Method for diagnosing in vitro pathologies associated with gene arrangements and diagnosis kits |
| 08/09/2000 | EP1025263A2 Labelling of polymers and sequencing of nucleic acids |
| 08/09/2000 | EP1025262A1 Screening for novel bioactivities |
| 08/09/2000 | EP1025261A1 Compositions and methods for determining predisposition to insulin dependent diabetes mellitus |
| 08/09/2000 | EP1025260A1 Test for crop damage |
| 08/09/2000 | EP1025259A1 Method for adjusting and disinfecting liquids |
| 08/09/2000 | EP1025258A1 Testing the effectiveness of a sterilization procedure |
| 08/09/2000 | EP1025256A2 Method for identifying binding ligands to receptors |
| 08/09/2000 | EP1025246A1 Methods for identifying nucleic acid sequences and (poly)peptides which increase the expression yields of functional periplasmic proteins |
| 08/09/2000 | EP1025238A2 Death associated kinase containing ankyrin repeats (dakar) |
| 08/09/2000 | EP1025237A2 Human checkpoint kinase, hcds1, compositions and methods |
| 08/09/2000 | EP1025236A2 Human checkpoint kinase, hcds1, compositions and methods |
| 08/09/2000 | EP1025224A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses |
| 08/09/2000 | EP1025223A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/09/2000 | EP1025220A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF |
| 08/09/2000 | EP1025219A2 Antisense oligonucleotide sequences as inhibitors of microorganisms |
| 08/09/2000 | EP1025217A1 Recombinational cloning using nucleic acids having recombination sites |
| 08/09/2000 | EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 08/09/2000 | EP1025211A2 Hyaluronan synthase gene and uses thereof |
| 08/09/2000 | EP1025206A1 Cell lines useful for (in vitro) assay for identification of carcinogens |
| 08/09/2000 | EP1025205A2 (in vitro) differentiation of vascular smooth muscle cells, methods and reagents related thereto |
| 08/09/2000 | EP1025203A1 Impaired brca2 function in cells and non-human transgenic animals |
| 08/09/2000 | EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR |
| 08/09/2000 | EP1025120A2 Methods, kits and compositions pertaining to pna molecular beacons |
| 08/09/2000 | EP1024900A1 Methods and apparatus for determining analytes in various matrices |
| 08/09/2000 | EP1024828A1 NOVEL pheS (BETA) |
| 08/09/2000 | EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 08/09/2000 | EP0786083B1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 08/09/2000 | EP0690914B1 Allergenic protein and peptides from house dust mite and uses therefor |
| 08/09/2000 | EP0533846B1 The ciliary neurotrophic factor receptor |
| 08/09/2000 | CN1262739A Substrate determining method |
| 08/09/2000 | CN1262688A Integrin binding peptide and use thereof |
| 08/09/2000 | CN1262629A High-throughput screening assay systems in microscale fluidic devices |
| 08/09/2000 | CN1055314C Cloning and over expression of glucose-6-phosphate dehydrogenase fro leuconostoc dextranicus |
| 08/08/2000 | US6100446 Plant cell transformed with nucleotide sequences which code a degratory enzymatic protein; for pollution control |
| 08/08/2000 | US6100445 Hybrid rodent with homogeneity for cytokine mutation; for prevention of apoptosis; antiproliferative agents |
| 08/08/2000 | US6100099 Chromatographic aparatus for the immunological detection of compounds; for the detection of target nucleotide sequences, antigens and antibodies |
| 08/08/2000 | US6100089 Using animal cell in culture which has stably integrated laci gene (the lac repressor), lac operator, and reporter gene; exposure to compound which mutates laci gene causes detectable expression of reporter gene |
| 08/08/2000 | US6100079 Method for treating biopolymers, microorganisms or materials by using more than one type of magnetic particles |
| 08/08/2000 | US6100078 Purified DNA polymerase from bacillus stearothermophilus ATCC 12980 |
| 08/08/2000 | US6100076 Amino acid sequence of enzyme which glycosylates an epidermal growth factor domain of a polypeptide with an activated fucose moiety |
| 08/08/2000 | US6100075 Delta 1-pyrroline-5-carboxylate reductase homolog |
| 08/08/2000 | US6100072 Preparing liquid or lyophilized reagent by mixing surfactant solubilized tissue factor with surfactant-free solution, suspension, or dispersion of phospholipid vessicle, incubating mixture to produce reagent; also fibrinogen levels |
| 08/08/2000 | US6100067 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes |
| 08/08/2000 | US6100064 Increasing secretion by culturing cells transformed with recombinant vector encoding cytomegalovirus gb protein that may have deactivated protease site and lacks transmembrane encoding domain but has cytoplasmic domain |
| 08/08/2000 | US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction |
| 08/08/2000 | US6100050 Factor VIII:Ca chromogenic assay |
| 08/08/2000 | US6100048 Using a panel of mammalian cells transformed with recombinant expression constructs encoding a variety of melanocortin receptors; contacting cells with compound, detecting binding, and determing if compound inhibits feeding behavior |
| 08/08/2000 | US6100046 Methods of identifying modulators of alpha9, a novel acetylcholine-gated ion channel receptor subunit |
| 08/08/2000 | US6100040 Methods and compositions for detection of specific nucleotide sequences |
| 08/08/2000 | US6100039 Mixing primer with rna, forming rna/dna duplex, removing rna, hybridizing dna with fluorescent-labeled oligonucleotide, measuring experimental polarization, comparing to known initial value; screening enzyme inhibitors for viricides |
| 08/08/2000 | US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents |
| 08/08/2000 | US6100035 Contacting nucleic acids bound to nucleic acid binding factors with a population of isolated nucleic acids, and identifying the isolated nucleic acids that bind to the nucleic acid binding factors |
| 08/08/2000 | US6100034 Detection of retroviral subtypes based upon envelope specific sequences |
| 08/08/2000 | US6100033 Diagnostic test for prenatal identification of Down's syndrome and mental retardation and gene therapy therefor |
| 08/08/2000 | US6100032 Human Smad3 and Smad4 are sequence-specific transcription activators |
| 08/08/2000 | US6100031 Hybridization assay using specific nucleotide sequence as probe |
| 08/08/2000 | US6100030 Use of selective DNA fragment amplification products for hybridization-based genetic fingerprinting, marker assisted selection, and high-throughput screening |
| 08/08/2000 | US6100029 Methods for the detection of chromosomal aberrations |
| 08/08/2000 | US6100028 DNA polymerase extension assay |
| 08/08/2000 | US6100027 Nucleotide seqeuences of mixture of hybridization probes specific for nesseria meningitidis; for detection in samples |
| 08/08/2000 | US6100024 Methods and compositions for nucleic acid detection by target extension and probe amplification |
| 08/08/2000 | US6100023 Drug design assay using human DNA polymerase α-catalytic polypeptide |
| 08/08/2000 | US6099804 Blood proteins and red blood cells will not stick to surface of membrane; resistance to repeated rinsing |
| 08/08/2000 | US6099803 Devices containing active electrodes especially adapted for electrophoretic transport of nucleic acids, their hybridization and analysis |